Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Bal Pharma Ltd.

  • NSE: BALPHARMA

  • BSE: 524824

  • Q
  • V
  • T
  • Expensive Performer
42.60/100

Quality Score

Medium Financial Strength
26.83/100

Valuation Score

Expensive Valuation
49.94/100

Technical Score

Technically Neutral
Broker Average Rating

0.00

Broker Average Rating

MFI

77.06

MFI Overbought

50Day SMA Rs

45.35 Rs

Price below SMA-50

Quality score

42.60

Medium Financial Strength

30Day SMA Rs

45.46 Rs

Price below SMA-30

Broker Covering stock

0.00

None Broker Covering stock

Broker 6M Target upgrade

0.00

None Broker 6M Target upgrade

Broker 6M Target downgrade

0.00

None Broker 6M Target downgrade

Momentum score

49.94

Technically Neutral

Price to Book Ratio

1.05

Below industry Median

Broker Reports in 1Yr

0.00

None Broker Reports in 1Yr

TTM PE Ratio

-6.25

Negative PE Trailing 12M

Broker 6M Reco upgrade

0.00

None Broker 6M Reco upgrade

RSI

47.99

RSI is mid-range

Net Profit Qtr Cr

0.28 Cr

Below industry Median

AVG Broker Target

0.00 %

No targets last year

Operating Revenues Qtr Cr

52.13 Cr

Above industry Median

MACD

-0.40

MACD below Signal and Center

Valuation score

26.83

Expensive Valuation

MACD Signal Line

-0.31

MACD below Signal and Center

FII holding holding %

0.00 %

FII holding holding

Promoter holding holding %

42.45 %

No change in Promoter holding

MF holding holding %

0.00 %

No change in MF holding

Broker 6M Reco downgrade

0.00

None Broker 6M Reco downgrade

100Day SMA Rs

42.99 Rs

Price above SMA 42.99

Institutions holding holding %

0.02 %

No change in Institutions holding

AVG Broker Target

0.00 Rs

No targets last year

200Day SMA Rs

41.55 Rs

Price above SMA 41.55

NSE BALPHARMA
44.80
  • 44.35 Close
  • 44.85 Open
  • 0.00 Volume
Today Low/High
Low 44.80
High 44.90
52 Week Low/High
23-03-2020 23.00
28-01-2020 53.90

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Bal Pharma Ltd. 44.8 -6.26 63.49 0 0.28 0 52.12 6.03 1.05
Sun Pharmaceutical Industries Ltd. 507.6 476.48 121788.46 0.78 -2429.81 0 7585.25 -9.43 2.47
Dr. Reddy's Laboratories Ltd. 5113 44.8 84978.06 0.48 586.9 0 4426.5 14.72 5.45
Divi's Laboratories Ltd. 3075.85 51.15 81648.43 0.52 492.06 0 1730.47 48.8 11.16
Cipla Ltd. 773.5 37.84 62363.43 0.51 571.42 0 4346.16 8.95 3.88
Aurobindo Pharma Ltd. 795.9 15.51 46631.78 0.53 792.68 0 5924.78 8.81 2.77
Torrent Pharmaceuticals Ltd. 2696.1 40.37 45628.79 1.18 321 0 2056 1.68 9.46
Lupin Ltd. 1000.3 -96.99 45323.59 0.59 108.14 0 3527.86 -20.16 3.6